| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Dec 11, 2024 | Option Exercise | $0.64 | 15,000 | 9,600 | 21,024 | Dec 13, 2024, 07:52 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Dec 11, 2024 | Sale | $12.43 | 15,000 | 186,426 | 6,024 | Dec 13, 2024, 07:52 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Dec 12, 2024 | Option Exercise | $0.64 | 25,000 | 16,000 | 31,024 | Dec 13, 2024, 07:52 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Dec 12, 2024 | Sale | $12.30 | 25,000 | 307,433 | 6,024 | Dec 13, 2024, 07:52 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Aug 20, 2024 | Sale | $15.00 | 50,000 | 750,000 | 6,024 | Aug 21, 2024, 06:51 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Aug 20, 2024 | Option Exercise | $0.64 | 50,000 | 32,000 | 56,024 | Aug 21, 2024, 06:51 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Aug 13, 2024 | Option Exercise | $0.64 | 30,000 | 19,200 | 36,024 | Aug 15, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Dorsey Brian | Chief Operating Officer | Aug 13, 2024 | Sale | $13.00 | 30,000 | 390,000 | 6,024 | Aug 15, 2024, 04:30 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | Dorsey Brian | Former SVP, Chief Dev Officer | Aug 30, 2018 | Option Exercise | $0.33 | 43,225 | 14,264 | 115,891 | Sep 04, 2018, 05:04 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | Dorsey Brian | SVP, Chief Development Officer | Jan 01, 2018 | Option Exercise | $1.84 | 5,485 | 10,092 | 159,116 | Jan 03, 2018, 07:45 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | Dorsey Brian | SVP, Chief Development Officer | Sep 05, 2017 | Option Exercise | $1.56 | 14,093 | 21,985 | 164,601 | Sep 07, 2017, 04:09 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | Dorsey Brian | SVP, Chief Development Officer | Feb 15, 2017 | Option Exercise | $2.78 | 1,495 | 4,156 | 103,694 | Mar 24, 2017, 04:13 PM | |
| APRI | APRICUS BIOSCIENCES, INC. | Dorsey Brian | Chief Development Officer | Dec 29, 2014 | Buy | $1.05 | 10,000 | 10,481 | 10,000 | Dec 30, 2014, 04:09 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Jan 03, 2012 | Sale | $0.48 | 9,000 | 4,289 | 134,452 | Jan 04, 2012, 01:53 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Dec 01, 2010 | Sale | $2.68 | 8,468 | 22,727 | 43,452 | Dec 03, 2010, 05:41 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Sep 01, 2010 | Sale | $4.27 | 3,000 | 12,810 | 51,920 | Sep 03, 2010, 05:24 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Sep 01, 2010 | Option Exercise | $1.23 | 3,000 | 3,690 | 54,920 | Sep 03, 2010, 05:24 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Aug 25, 2010 | Option Exercise | $1.23 | 5,000 | 6,150 | 56,920 | Aug 27, 2010, 06:35 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Aug 25, 2010 | Sale | $4.99 | 5,000 | 24,950 | 51,920 | Aug 27, 2010, 06:35 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Aug 10, 2010 | Option Exercise | $1.23 | 3,000 | 3,690 | 54,920 | Aug 13, 2010, 05:40 PM | |
| SOMX | Somaxon Pharmaceuticals, Inc. | Dorsey Brian | SVP, Technical Operations | Aug 10, 2010 | Sale | $3.99 | 3,000 | 11,970 | 51,920 | Aug 13, 2010, 05:40 PM |
Menu